Sumitomo Seika Chemicals (4008) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Jul, 2026Executive summary
Net sales for FY2025 2Q were ¥72.7 billion, down 1.7% year-over-year, mainly due to the termination of the IR latex business and yen appreciation, despite increased Super Absorbent Polymers (SAP) sales volume.
Operating profit rose 19.9% to ¥5.9 billion, driven by lower raw material and fuel costs.
Ordinary profit increased 18.0% to ¥5.6 billion.
Profit attributable to owners declined 1.6% to ¥3.3 billion due to extraordinary losses related to mischarges.
Comprehensive income surged 232% year-over-year to ¥4,272 million.
Financial highlights
Gross profit increased to ¥16,236 million from ¥14,925 million year-over-year.
Operating profit margin improved, with operating profit at ¥5,881 million versus ¥4,905 million a year earlier.
Net assets rose to ¥97,294 million, and the equity-to-asset ratio improved to 68.2%.
Full-year FY2025 forecast: net sales ¥145.0 billion (-1.7% YoY), operating profit ¥11.3 billion (+5.5%), net profit ¥4.4 billion (-26.2%).
Cash flows from operating activities increased to ¥6,882 million, while investing activities used ¥4,546 million.
Outlook and guidance
SAP sales volume expected to grow, but net sales to decline due to yen strength and IR latex business termination.
Operating profit forecast to rise on lower input costs; net profit to fall due to extraordinary losses and restructuring costs.
Dividend forecast maintained at ¥200/share; treasury stock acquisition planned.
Basic earnings per share for the year ending March 31, 2026, is projected at ¥336.90.
Latest events from Sumitomo Seika Chemicals
- Ambitious 2045 vision and FY2030 targets set, with focus on sustainability and capital efficiency.4008
Investor presentation6 Aug 2026 - Strong sales and profit growth, but FY2027 outlook tempered by rising costs and global risks.4008
Q1 20276 Aug 2026 - Sales and operating profit rose, but profit fell on one-time losses; outlook cautious.4008
Q4 202520 Jul 2026 - Profits and shareholder returns rose, but outlook is uncertain due to Middle East risks.4008
Q4 202620 Jul 2026 - Operating profit rose despite lower sales, with strong shareholder returns and capacity expansion.4008
Q2 202520 Jul 2026 - Profits fell sharply on lower sales and business exits, but full-year profit is forecast to recover.4008
Q1 202520 Jul 2026 - Profits surged on strong polymer sales and FX gains, prompting an upward revision to forecasts.4008
Q3 202520 Jul 2026 - Profits fell sharply year-over-year, but full-year net profit is forecast to rise on one-time factors.4008
Q1 202620 Jul 2026 - Operating profit rose 18.7% despite lower sales, with full-year profit forecast revised upward.4008
Q3 202620 Jul 2026